Balentine LLC Novartis Ag Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $49,349 - $56,187	518 Added 1.87%	28,257 $2.73 Million
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $249,036 - $274,056	2,699 Added 10.78%	27,739 $2.8 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $550,760 - $611,225	5,814 Added 30.24%	25,040 $2.55 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $6,291 - $7,133	68 Added 0.35%	19,226 $1.94 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $172,144 - $199,634	2,151 Added 12.65%	19,158 $1.76 Million
Q4 2022 Jan 31, 2023	BUY	$75.55 - $92.52 $176,560 - $216,219	2,337 Added 15.93%	17,007 $1.54 Million
Q3 2022 Oct 26, 2022	SELL	$74.61 - $87.26 $379,914 - $444,327	-5,092 Reduced 25.77%	14,670 $1.12 Million
Q2 2022 Oct 26, 2022	BUY	$80.52 - $93.75 $731,926 - $852,187	9,090 Added 85.18%	19,762 $1.67 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $731,926 - $852,187	9,090 Added 85.18%	19,762 $1.67 Million
Q1 2022 Oct 26, 2022	SELL	$80.11 - $90.62 $728,199 - $823,735	-9,090 Reduced 46.0%	10,672 $936,000
Q1 2022 May 06, 2022	BUY	$80.11 - $90.62 $283,429 - $320,613	3,538 Added 49.59%	10,672 $936,000
Q4 2021 Oct 26, 2022	SELL	$79.7 - $88.13 $1.01 Million - $1.11 Million	-12,628 Reduced 63.9%	7,134 $624,000
Q4 2021 Feb 02, 2022	BUY	$79.7 - $88.13 $132,222 - $146,207	1,659 Added 30.3%	7,134 $624,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $27,478 - $31,967	336 Added 6.54%	5,475 $448,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $35,289 - $38,978	414 Added 8.76%	5,139 $469,000
Q1 2021 May 10, 2021	BUY	$83.5 - $98.47 $36,072 - $42,539	432 Added 10.06%	4,725 $404,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $53,477 - $64,684	685 Added 18.99%	4,293 $405,000
Q3 2020 Nov 02, 2020	BUY	$82.14 - $91.0 $98,978 - $109,655	1,205 Added 50.15%	3,608 $314,000
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $194,474 - $218,913	2,403 New	2,403 $210,000
Q4 2019 Sep 02, 2020	SELL	$84.35 - $95.37 $83,759 - $94,702	-993 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $11,687 - $14,384	155 Added 18.5%	993 $91,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $39,629 - $44,126	538 Added 179.33%	838 $72,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $20,082 - $23,229	300 New	300 $26,000
Q1 2018 May 16, 2018	SELL	$70.39 - $84.15 $19,216 - $22,972	-273 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$74.14 - $77.27 $20,240 - $21,094	273	273 $23,000

Others Institutions Holding NVS

# of Institutions

1,423

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account